Endocrine late effects of childhood cancer therapy: A report from the children's oncology group

Hormone Research

Volumn 69, Issue 2, 2008, Pages 65-74

  Nandagopal, Radha ^a,e   Laverdière, Caroline ^b   Mulrooney, Daniel ^c   Hudson, Melissa M ^d   Meacham, Lillian ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MONTREAL   (Canada)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^e CHILDREN S ONCOLOGY GROUP   (United States)

Author keywords

Chemotherapy; Childhood cancer; Endocrine late effects; Pediatrics; Radiation therapy

Indexed keywords

ALKALOID DERIVATIVE; ALKYLATING AGENT; ANTHRACYCLINE DERIVATIVE; ANTIMETABOLITE; ANTINEOPLASTIC ANTIBIOTIC; CORTICOSTEROID DERIVATIVE; ENZYME; EPIPODOPHYLLOTOXIN DERIVATIVE;

ADRENAL INSUFFICIENCY; BONE DENSITY; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER SCREENING; CANCER SURGERY; CANCER SURVIVOR; CANCER THERAPY; CHILDHOOD CANCER; CLINICAL PRACTICE; FOLLOW UP; GONADOTROPIN DEFICIENCY; GROWTH HORMONE DEFICIENCY; HUMAN; HYPERLIPIDEMIA; HYPERPROLACTINEMIA; HYPERTHYROIDISM; HYPOGONADISM; HYPOTHYROIDISM; INFERTILITY; METABOLIC SYNDROME X; OBESITY; PRACTICE GUIDELINE; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; RADIATION DOSE; SHORT SURVEY; SIDE EFFECT; SKULL IRRADIATION; STEM CELL TRANSPLANTATION; THYROID CANCER; THYROID NODULE; WHOLE BODY RADIATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CONSENSUS; ENDOCRINE SYSTEM; ENDOCRINE SYSTEM DISEASES; FOLLOW-UP STUDIES; GUIDELINES AS TOPIC; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; NEOPLASMS; RADIOTHERAPY, CONFORMAL; SKULL; TIME FACTORS; WHOLE-BODY IRRADIATION;

EID: 38349009219     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111809     Document Type: Short Survey

References (46)

1. Bhatia S: Cancer survivorship - pediatric issues. Hematology Am Soc Hematol Educ Program 2005;507-515.
2. Cohen LE: Endocrine late effects of cancer treatment. Endocrinol Metab Clin North Am 2005;34:769-789.
3. Marina N: Long-term survivors of childhood cancer. The medical consequences of cure. Pediatr Clin North Am 1997;44:1021-1042.
4. Sklar C, Boulad F, Small T, Kernan N: Endocrine complications of pediatric stem cell transplantation. Front Biosci 2001;6:G17-G22.
5. Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, Friedman DL, Marina N, Hobbie W, Kadan-Lottick NS, Schwartz CL, Leisenring W, Robison LL: Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006;355:1572-1582.
6. Gleeson HK, Shalet SM: Endocrine complications of neoplastic diseases in children and adolescents. Curr Opin Pediatr 2001;13:346-351.
7. Meacham L: Endocrine late effects of childhood cancer therapy. Curr Probl Pediatr Adolesc Health Care 2003;33:217-242.
8. Landier W, Wallace WH, Hudson MM: Long-term follow-up of pediatric cancer survivors: education, surveillance, and screening. Pediatr Blood Cancer 2006;46:149-158.
9. Landier W, Bhatia S, Eshelman DA, Forte KJ, Sweeney T, Hester AL, Darling J, Armstrong FD, Blatt J, Constine LS, Freeman CR, Friedman DL, Green DM, Marina N, Meadows AT, Neglia JP, Oeffinger KC, Robison LL, Ruccione KS, Sklar CA, Hudson MM: Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 2004;22:4979-4990.
10. Gleeson HK, Shalet SM: The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours. Endocr Relat Cancer 2004;11:589-602.
11. Shalet SM, Beardwell CG, Morris-Jones P, Bamford FN, Ribeiro GG, Pearson D: Growth hormone deficiency in children with brain tumors. Cancer 1976;37:1144-1148.
12. Constine LS, Woolf PD, Cann D, Mick G, McCormick K, Raubertas RF, Rubin P: Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med 1993;328:87-94.
13. Brownstein CM, Mertens AC, Mitby PA, Stovall M, Qin J, Heller G, Robison LL, Sklar CA: Factors that affect final height and change in height standard deviation scores in survivors of childhood cancer treated with growth hormone: a report from the childhood cancer survivor study. J Clin Endocrinol Metab 2004;89:4422-4427.
14. Costin G: Effects of low-dose cranial radiation on growth hormone secretory dynamics and hypothalamic-pituitary function. Am J Dis Child 1988;142:847-852.
15. Chrousos GP, Poplack D, Brown T, O'Neill D, Schwade J, Bercu BB: Effects of cranial radiation on hypothalamic-adenohypophyseal function: abnormal growth hormone secretory dynamics. J Clin Endocrinol Metab 1982;54:1135-1139.
16. Oberfield SE, Soranno D, Nirenberg A, Heller G, Allen JC, David R, Levine LS, Sklar CA: Age at onset of puberty following high-dose central nervous system radiation therapy. Arch Pediatr Adolesc Med 1996;150:589-592.
17. Ogilvy-Stuart AL, Clayton PE, Shalet SM: Cranial irradiation and early puberty. J Clin Endocrinol Metab 1994;78:1282-1286.
18. Mills JL, Fears TR, Robison LL, Nicholson HS, Sklar CA, Byrne J: Menarche in a cohort of 188 long-term survivors of acute lymphoblastic leukemia. J Pediatr 1997;131:598-602.
19. Rose SR, Lustig RH, Pitukcheewanont P, Broome DC, Burghen GA, Li H, Hudson MM, Kun LE, Heideman RL: Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. J Clin Endocrinol Metab 1999;84:4472-4479.
20. Livesey EA, Brook CG: Thyroid dysfunction after radiotherapy and chemotherapy of brain tumours. Arch Dis Child 1989;64:593-595.
21. Rose SR, Danish RK, Kearney NS, Schreiber RE, Lustig RH, Burghen GA, Hudson MM: ACTH deficiency in childhood cancer survivors. Pediatr Blood Cancer 2005;45:808-813.
22. Oberfield SE, Nirenberg A, Allen JC, Cohen H, Donahue B, Prasad V, Schiff R, Pang S, Ghavimi F, David R, Chrousos G, Sklar C: Hypothalamic-pituitary- adrenal function following cranial irradiation. Horm Res 1997;47:9-16.
23. Schmiegelow M, Feldt-Rasmussen U, Rasmussen AK, Lange M, Poulsen HS, Muller J: Assessment of the hypothalamo-pituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor. J Clin Endocrinol Metab 2003;88:3149-3154.
24. Sklar CA, Constine LS: Chronic neuroendocrinological sequelae of radiation therapy. Int J Radiat Oncol Biol Phys 1995;31:1113-1121.
25. Oeffinger KC, Mertens AC, Sklar CA, Yasui Y, Fears T, Stovall M, Vik TA, Inskip PD, Robison LL: Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2003;21:1359-1365.
26. Gurney JG, Kadan-Lottick NS, Packer RJ, Neglia JP, Sklar CA, Punyko JA, Stovall M, Yasui Y, Nicholson HS, Wolden S, McNeil DE, Mertens AC, Robison LL: Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer 2003;97:663-673.
27. Brennan BM, Shalet SM: Endocrine late effects after bone marrow transplant. Br J Haematol 2002;118:58-66.
28. Sigurdson AJ, Ronckers CM, Mertens AC, Stovall M, Smith SA, Liu Y, Berkow RL, Hammond S, Neglia JP, Meadows AT, Sklar CA, Robison LL, Inskip PD: Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study. Lancet 2005;365:2014-2023.
29. Sklar C: Maintenance of ovarian function and risk of premature menopause related to cancer treatment. J Natl Cancer Inst Monogr 2005;34:25-27.
30. Howell SJ, Shalet SM: Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr 2005;34:12-17.
31. Kenney LB, Laufer MR, Grant FD, Grier H, Diller L: High risk of infertility and longterm gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer 2001;91:613-621.
32. Howell SJ, Shalet SM: Testicular function following chemotherapy. Hum Reprod Update 2001;7:363-369.
33. Gleeson HK, Darzy K, Shalet SM: Late endocrine, metabolic and skeletal sequelae following treatment of childhood cancer. Best Pract Res Clin Endocrinol Metab 2002;16:335-348.
34. Taskinen M, Saarinen-Pihkala UM, Hovi L, Lipsanen-Nyman M: Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet 2000;356:993-997.
35. Teinturier C, Hartmann O, Valteau-Couanet D, Benhamou E, Bougneres PF: Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure. Bone Marrow Transplant 1998;22:989-994.
36. Afify Z, Shaw PJ, Clavano-Harding A, Cowell CT: Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide. Bone Marrow Transplant 2000;25:1087-1092.
37. Gerl A, Muhlbayer D, Hansmann G, Mraz W, Hiddemann W: The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumors. Cancer 2001;91:1297-1303.
38. Sklar C: Reproductive physiology and treatment-related loss of sex hormone production. Med Pediatr Oncol 1999;33:2-8.
39. Muller J: Disturbance of pubertal development after cancer treatment. Best Pract Res Clin Endocrinol Metab 2002;16:91-103.
40. Kaste SC: Bone-mineral density deficits from childhood cancer and its therapy. A review of at-risk patient cohorts and available imaging methods. Pediatr Radiol 2004;34:373-378, 443-374.
41. Kaste SC, Jones-Wallace D, Rose SR, Boyett JM, Lustig RH, Rivera GK, Pui CH, Hudson MM: Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development. Leukemia 2001;15:728-734.
42. Raghavan D, Cox K, Childs A, Grygiel J, Sullivan D: Hypercholesterolemia after chemotherapy for testis cancer. J Clin Oncol 1992;10:1386-1389.
43. Ellis PA, Fitzharris BM, George PM, Robinson BA, Atkinson CH, Colls BM: Fasting plasma lipid measurements following cisplatin chemotherapy in patients with germ cell tumors. J Clin Oncol 1992;10:1609-1614.
44. Stein J, Dini G, Yaniv I: The hope and the reality of reduced intensity transplants in children with malignant diseases. Bone Marrow Transplant 2005;35(suppl 1):S39-S43.
45. Baker KS, Gurney JG, Ness KK, Bhatia R, Forman SJ, Francisco L, McGlave PB, Robison LL, Snyder DS, Weisdorf DJ, Bhatia S: Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study. Blood 2004;104:1898-1906.
46. Bhatia S, Ramsay NK, Weisdorf D, Griffiths H, Robison LL: Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies. Bone Marrow Transplant 1998;22:87-90.